NASDAQ:MARA - Marathon Patent Group Stock Price, News & Analysis

Marathon Patent Group trades on the NASDAQ under the ticker symbol "MARA."

Marathon Patent Group shares reverse split on the morning of Monday, October 30th 2017. The 1-4 reverse split was announced on Friday, October 27th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 27th 2017. An investor that had 100 shares of Marathon Patent Group stock prior to the reverse split would have 25 shares after the split.

Marathon Patent Group Inc (NASDAQ:MARA) announced its quarterly earnings results on Thursday, August, 1st. The business services provider reported ($0.09) earnings per share (EPS) for the quarter. The business services provider earned $0.36 million during the quarter. Marathon Patent Group had a negative net margin of 601.64% and a negative return on equity of 222.88%. View Marathon Patent Group's Earnings History.

Marathon Patent Group is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Marathon Patent Group.

News coverage about MARA stock has been trending negative recently, according to InfoTrie. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Marathon Patent Group earned a daily sentiment score of -2.9 on InfoTrie's scale. They also assigned media headlines about the business services provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Marathon Patent Group.

Marathon Patent Group saw a decline in short interest in August. As of August 15th, there was short interest totalling 450,900 shares, a decline of 20.0% from the July 15th total of 563,500 shares. Based on an average daily volume of 414,300 shares, the short-interest ratio is currently 1.1 days. Currently, 3.7% of the shares of the stock are sold short. View Marathon Patent Group's Current Options Chain.

Some companies that are related to Marathon Patent Group include XCel Brands (XELB), MGT Capital Investments (MGTI), ARC Group (ARCK), Spherix (SPEX), XpresSpa Group (XSPA), Patriot Scientific (PTSC), American Restaurant Partners LP Class A Partnership Units (ICTPU), Fortel (ECGP), Health Discovery (HDVY) and Micro Imaging Technology (MMTC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Marathon Patent Group investors own include Sierra Wireless (SWIR), MannKind (MNKD), Neovasc (NVCN), Bausch Health Companies (BHC), PTC Therapeutics (PTCT), Alibaba Group (BABA), Biocept (BIOC), Micron Technology (MU), Arena Pharmaceuticals (ARNA) and Riot Blockchain (RIOT).

Marathon Patent Group's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (4.26%). View Institutional Ownership Trends for Marathon Patent Group.

MARA stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. View Insider Buying and Selling for Marathon Patent Group.

Shares of MARA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MARA stock can currently be purchased for approximately $1.84.

Marathon Patent Group has a market capitalization of $11.75 million and generates $1.56 million in revenue each year. Marathon Patent Group employs 3 workers across the globe.View Additional Information About Marathon Patent Group.

The official website for Marathon Patent Group is http://www.marathonpg.com/.

Marathon Patent Group's mailing address is 1180 North Town Center Drive Suite 100, LAS VEGAS NV, 89144. The business services provider can be reached via phone at 702-945-2773 or via email at [email protected]